Nurix Therapeutics Reports First Clinical Evidence of CNS

Presented new case studies demonstrating clinical responses in two patients with B cell malignancies, chronic lymphocytic leukemia (CLL) and primary...

Related Keywords

United States ,California ,San Francisco ,San Diego ,American ,Jason Kantor ,Arthurt Sands ,Gwennm Hansen ,Elizabeth Wolffe ,Gen Degraders ,Aljanae Reynolds ,American Association For Cancer Research ,Nurix Therapeutics Inc ,Nasdaq ,American Association ,Cancer Research ,Major Symposium ,Molecular Glues ,Next Gen Degraders ,Early Preclinical Advances ,Central Nervous System ,Casitasb Lineage ,Private Securities Litigation Reform Act ,Annual Report ,Life Science ,